Cargando…
Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study
BACKGROUND: We conducted Mendelian randomization analyses investigating the linear associations of genetically proxied inhibition of different coagulation factors with risk of common cardiovascular diseases. METHODS AND RESULTS: Genetic instruments proxying coagulation factor inhibition were identif...
Autores principales: | Yuan, Shuai, Burgess, Stephen, Laffan, Mike, Mason, Amy M., Dichgans, Martin, Gill, Dipender, Larsson, Susanna C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174173/ https://www.ncbi.nlm.nih.gov/pubmed/33834859 http://dx.doi.org/10.1161/JAHA.120.019644 |
Ejemplares similares
-
Genetically proxied interleukin-6 receptor inhibition: opposing associations with COVID-19 and pneumonia
por: Larsson, Susanna C., et al.
Publicado: (2021) -
Genetically Determined Platelet Count and Risk of Cardiovascular Disease: Mendelian Randomization Study
por: Gill, Dipender, et al.
Publicado: (2018) -
Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes
por: Gill, Dipender, et al.
Publicado: (2020) -
Genetic liability to insomnia in relation to cardiovascular diseases: a Mendelian randomisation study
por: Yuan, Shuai, et al.
Publicado: (2021) -
Dose–response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus
por: Burgess, Stephen, et al.
Publicado: (2021)